AGAMREE Oral suspension Ref.[107213] Active ingredients: Vamorolone

Source: European Medicines Agency (EU)  Revision Year: 2024  Publisher: Santhera Pharmaceuticals (Deutschland) GmbH, Marie-Curie Strasse 8, D-79539 Lรถrrach, GERMANY, office@santhera.com

Product name and form

AGAMREE 40 mg/ml oral suspension.

Pharmaceutical Form

Oral suspension.

White to off-white suspension.

Qualitative and quantitative composition

Each ml of suspension contains 40 mg of vamorolone.

Excipient with known effect: The suspension contains 1 mg sodium benzoate (E211) in each ml.

For the full list of excipients, see section 6.1.

Active Ingredient Description
Vamorolone

Vamorolone is a dissociative corticosteroid that selectively binds to the glucocorticoid receptor, which triggers anti-inflammatory effects via inhibition of NF-kB mediated gene transcripts, but leads to less transcriptional activation of other genes. In addition, vamorolone inhibits the activation of the mineralocorticoid receptor by aldosterone. Due to its specific structure, vamorolone is likely not a substrate for 11ฮฒ-hydroxysteroid dehydrogenases and is therefore not subject to local tissue amplification. The precise mechanism by which vamorolone exerts its therapeutic effects in patients with DMD is unknown.

List of Excipients

Citric acid (monohydrate) (E330)
Disodium phosphate (E339)
Glycerol (E422)
OrangEflavour
Purified water
Sodium benzoate (E211)
Sucralose (E955)
Xanthan gum (E415)
Hydrochloric acid (for pH adjustment)

Pack sizes and marketing

Amber coloured glass bottle containing 100 ml oral suspension with a polypropylene tamper evident child resistant closure with low density polyethylene liner.

Each pack contains one bottle, one press-in bottle adapter (low density polyethylene) and two identical oral syringes (low density polyethylene) graduated from 0 to 8 ml by increments of 0.1 ml.

Marketing authorization holder

Santhera Pharmaceuticals (Deutschland) GmbH, Marie-Curie Strasse 8, D-79539 Lรถrrach, GERMANY, office@santhera.com

Marketing authorization dates and numbers

EU/1/23/1776/001

Drugs

Drug Countries
AGAMREE Austria, Estonia, Croatia, Ireland, Lithuania, United States

ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.